Abstract:Ventricular septal defects (VSDs) are the most common type of congenital head diseases (CHDs). To date, the genetic causes for sporadic VSDs remain largely unknown. GATA transcription factor 4 (GATA4) is a zinc-finger transcription factor that is expressed in developing heart and adult cardiomyocytes. Mutations in the coding region of the GATA4 gene have been identified in CHD patients, including VSD. As the GATA4 factor is a dosage-sensitive regulator, we hypothesized that the promoter region variants of the GATA4 gene may be genetic causes of VSD. In this study, we analyzed the promoter region of the GATA4 gene by bidirectional sequencing in 172 VSD patients and 171 healthy controls. The results showed that 5 heterozygous sequence variants (NG_008177:g.4071T>C, NG_008177:g.4148C>A, NG_008177:g.4566C>T, NG_008177:g.4653G>T, and NG_008177:g.4690G>deletion) within the promoter region of the GATA gene were identified in 5 VSD patients, but in none of controls. One heterozygous sequence variant (g.4762C>A) was found only in one control, which may have no functional significance. A functional analysis revealed that the transcriptional activity of variant NG_008177:g.4566C>T was reduced significantly, whereas the transcriptional activities of the variants (NG_008177:g.4071T>C, NG_008177:g.4148C>A, NG_008177:g.4653G>T, and NG008177:g.4690G>deletion) were increased significantly compared with the wild-type GATA4 gene promoter. As GATA4 is a dosage-sensitive regulator during development, our data suggest that these sequence variants within the promoter region of the GATA4 gene may contribute to the VSD etiology by altering its gene expression. Additional studies in experimental animals will deepen our understanding of the genetic basis of VSD and shed light on designing novel molecular therapies for adult VSD patients carrying these variants. (Translational Research 2012;159:376-382)

GATA4 Loss-of-Function Mutation and the Congenitally Bicuspid Aortic Valve.

GATA6 Loss-of-function Mutation Contributes to Congenital Bicuspid Aortic Valve

GATA 5 Loss-of-function Mutations Associated with Congenital Bicuspid Aortic Valve

A Novel Gata4 Mutation Responsible for Congenital Ventricular Septal Defects

Targeted Next-Generation Sequencing Identified ADAMTS5 As Novel Genetic Substrate in Patients with Bicuspid Aortic Valve.

[A Novel GATA4 Mutation Leading to Congenital Ventricular Septal Defect].

Analysis on mutational spectrum of GATA5 gene associated with bicuspid aortic valve

A Novel GATA4 Loss-of-Function Mutation Associated with Congenital Ventricular Septal Defect

[Novel GATA4 Mutations Identified in Patients with Congenital Atrial Septal Defects].

A novel NKX2.5 loss-of-function mutation associated with congenital bicuspid aortic valve.

NR2F2 Loss‑of‑function Mutation is Responsible for Congenital Bicuspid Aortic Valve

Involvement Of A Novel Gata4 Mutation In Atrial Septal Defects

Elucidation of the genetic causes of bicuspid aortic valve disease

A Novel GATA6 Mutation in Patients with Tetralogy of Fallot or Atrial Septal Defect

An Interesting Mybpc3 Heterozygous Mutation Associated with Bicuspid Aortic Valve

A Novel Mutation of GATA4 (K319E) is Responsible for Familial Atrial Septal Defect and Pulmonary Valve Stenosis

Mutation analysis of GATA4 gene in Han Chinese patients with atrioventricular septal defect

GATA4 Mutations and Sporadic Congenital Heart Disease

[Novel GATA4 Mutations Identified in Patients with Congenital Heart Disease].

The c.1039 G>A single nucleotide polymorphisms in VEGFA gene are associated with the increased risk for bicuspid aortic valve

Genetic analysis of the promoter region of the GATA4 gene in patients with ventricular septal defects.